CB Insights studied 431 startup shutdowns in 2025 and found that 43% died from poor product-market fit (CB Insights, 2025). That’s not a coding problem or a marketing problem. It’s a demand problem. Most founders can’t tell the difference between an idea that excites them and a problem that’s urgent to a buyer, and that gap is where months of work quietly go to waste.
This post gives you a 5-minute, 3-question test to score any idea before you spend another hour on it. It’s the same filter taught as the very first lesson in the Ideas Into Income validation curriculum, before a single member is allowed to start building.
Key Takeaways – A painkiller solves an urgent, costly problem people are already trying to fix; a vitamin is nice-to-have and easy to postpone. – Score your idea against 3 pain markers: urgent, costly, already-being-worked-around. 2+ yeses means keep going. – Among a 2022 cohort of SaaS unicorns, roughly 80% were classified as painkillers, not vitamins (SaaS Club / Knight Capital, 2022, directional industry analysis). – There’s a third, overlooked category, “candy”, that plays by different rules entirely. – 43% of startup failures trace back to poor product-market fit (CB Insights, 2025).
What’s the difference between a painkiller and a vitamin idea?
A painkiller solves a problem that’s urgent, costly, and already being fought with a clumsy workaround; a vitamin makes life a little better but is easy to postpone indefinitely. That distinction alone explains a huge share of startup outcomes: CB Insights found 43% of 431 studied shutdowns in 2025 cited poor product-market fit as the root cause (CB Insights, 2025).
Vitamins are hard to sell for a simple reason: nobody wakes up in pain over something that’s merely “nice.” You have to convince a stranger the improvement is worth their money, and that’s an uphill argument every single day. A painkiller flips the script entirely. The buyer already knows they have a problem. They’re often already spending money on a bad fix. Your job isn’t to invent desire, it’s to redirect demand that already exists toward a better answer.
That redirection is the whole game. Think about someone who just missed a client deadline because their invoicing spreadsheet crashed, again. They don’t need convincing that invoicing software matters, they’re already Googling a fix at 11 p.m. Compare that to a habit-tracking app for people who are already reasonably organized. Same category, wildly different urgency.
Here’s the part most founders skip: running out of cash is usually just the symptom. CB Insights’ same 2025 report found 70% of the failed startups cited running out of capital (CB Insights, 2025), but the report itself calls that a downstream effect. You don’t run out of money building the right thing nearly as often as you do building the wrong one.
There’s a survival-rate backdrop worth knowing too. About 1 in 5 new US businesses close within their first year, and roughly half are gone within five years, according to Bureau of Labor Statistics data reported by LendingTree (LendingTree, 2025). That failure curve isn’t random. It tracks closely with how many of those businesses were solving a real, urgent pain versus a pleasant-to-have.
Citation capsule: Painkillers solve problems that are urgent, costly, and already being worked around with a clumsy fix; vitamins are postponable improvements. CB Insights’ 2025 study of 431 startup shutdowns found 43% failed on poor product-market fit, the exact gap this test is built to catch (CB Insights, 2025).
Want the full validation method this test feeds into? See the full 7-day validation sprint.
The overlooked third category: is your idea “candy”?
Candy is fun, social, or good-looking, but it’s neither urgent nor deeply needed, and most painkiller-versus-vitamin guides never mention it. A candy product can absolutely work; it just runs on different fuel than a painkiller does. Instead of urgency, it needs virality and habit loops to keep people coming back.
Think of a novelty photo filter app, a meme generator, or a fun quiz site. Nobody is in pain without them, and nobody would call them “nice to have” in the vitamin sense either. People use candy because it’s delightful in the moment, not because it solves anything. That’s precisely why growth for candy products lives or dies on shareability, not on demand you can interview your way into.
The quickest way to spot a candy idea: ask whether people would genuinely miss it if it vanished tomorrow. If the honest answer is “they’d enjoy it while it’s here but shrug if it’s gone,” you’re holding candy. That’s not a death sentence, but it does mean your growth plan needs to look completely different from a painkiller’s plan.
Most guides stop at two categories because two is tidy. Real ideas rarely sort that cleanly, and pretending your idea is a painkiller when it’s actually candy is how founders build the wrong distribution strategy from day one.
The 3 pain markers: score your idea in 5 minutes
Score your idea yes or no on three markers: is it urgent, is it costly, and are people already working around it? Two or more yeses means you’re likely holding a painkiller worth pursuing further. This is the exact scoring rule taught in Lesson 1.1.2 of the Ideas Into Income validation curriculum.
Here’s what each marker actually means, with a concrete example pair so it’s not abstract.
Marker 1: Is it urgent?
Urgent means the person needs it fixed now, not eventually. A meal-planning app is a vitamin: nice to have, easy to shelve for another week. “How do I feed my picky toddler tonight” is a painkiller: the deadline is dinner, and it’s not moving. (This pairing is illustrative only, not a real client case study.)
Marker 2: Is it costly?
Costly means the problem drains money, time, or status if it stays unsolved. A general productivity app is a vitamin, mild inconvenience at worst. A freelancer who just lost a client because invoices went out late is bleeding real income, that’s costly, and that’s a painkiller signal.
Marker 3: Are they already working around it?
This is the tell most people miss. If someone has already duct-taped together a spreadsheet, a Facebook group thread, or a $40-a-month tool they hate, that’s proof of existing demand. You’re not asking them to want something new, you’re offering to replace a fix they already tolerate.
Citation capsule: Score any idea against three pain markers, urgent, costly, and already being worked around, and count the yeses. Two or more yeses signals a likely painkiller worth building. This is the exact 2-yes threshold used in the Ideas Into Income Academy’s validation curriculum, Lesson 1.1.2, as the first filter before any building begins.
That’s the whole test. Five minutes, three questions, one honest score.
Real examples: same niche, painkiller vs. vitamin version
The fastest way to internalize this test is to see the same niche split two ways, one soft and one sharp. Below are three illustrative pairs; none represent actual client outcomes or Academy case studies, they’re here purely to make the abstract test concrete.
Fitness. A general workout-tracking app is a vitamin — useful, but easy to abandon after two weeks. “I have a wedding in 6 weeks and nothing fits” is a painkiller: an urgent deadline with real embarrassment at stake, and the person is often already crash-dieting or googling desperate fixes.
Productivity. A note-taking app for “organizing your thoughts” is a vitamin — pleasant and forgettable. “I keep missing invoice deadlines and losing clients over it” is a painkiller: it’s costly in lost income, and it’s already causing pain today, not someday.
Freelancing. A general “freelancer community” app is a vitamin — nice for belonging, easy to skip. “I have zero clients and rent is due in 12 days” is a painkiller: urgent, costly, and the freelancer is almost certainly already cold-emailing strangers or slashing rates to compensate.
Notice the pattern across all three pairs. The vitamin version describes a category (“fitness,” “productivity,” “freelancing”). The painkiller version describes a moment with a deadline, a cost, and a workaround already in motion. That specificity is the tell.
Do most successful businesses start as painkillers?
Among a cohort of SaaS unicorns from Q1 2022, roughly 80% were classified as painkillers versus under 20% as vitamins, according to an industry analysis by SaaS Club, citing Knight Capital’s framework (SaaS Club / Knight Capital, 2022). Flag this one honestly: it’s a directional industry analysis, not a peer-reviewed study, but the pattern lines up with everything else in this post.
The takeaway isn’t that vitamins are doomed. It’s that painkillers have a structural head start: the demand already exists, so growth is a redirection problem rather than an invention problem. Vitamin businesses face a harder, slower climb because they have to manufacture desire from scratch.
Vitamins with a real distribution edge still win, though. Early Instagram and early Slack are the classic counterexamples: neither solved an urgent, costly pain on day one, but both rode a distribution advantage (a viral filter loop, an internal team habit that spread company to company) that let them build demand faster than a typical vitamin ever could. The lesson isn’t “vitamins never work.” It’s “vitamins need something extra that painkillers get for free.”
Citation capsule: Roughly 80% of a Q1 2022 cohort of SaaS unicorns were classified as painkillers versus under 20% vitamins, per an industry analysis by SaaS Club citing Knight Capital’s framework. The finding is directional, not peer-reviewed, but it reinforces why urgent-pain ideas dominate successful outcomes (SaaS Club / Knight Capital, 2022).
Related: the weekend validation sprint — test your idea in 48 hours.
What if your idea scores as a vitamin?
Don’t abandon a vitamin idea outright. Instead, either dig for the urgent painkiller hiding inside it, or pair it with a real distribution edge before you build anything else. Startup Genome’s analysis of more than 3,200 startups found roughly 70% scaled prematurely, pouring resources into growth before confirming anyone actually wanted the product (Startup Genome). A vitamin idea scaled the same way just gets there faster and fails harder.
The reframe technique is simple: ask what specific, urgent moment sits underneath your nice-to-have idea. A general meal-planning app is a vitamin. But “what do I feed a picky toddler in the next 20 minutes” is a painkiller wearing a meal-planning app’s clothes. Same broad space, sharper edge.
If you genuinely can’t find a painkiller hiding inside your idea, the honest move is to pair it with a real unfair advantage, an existing audience, a distribution channel, or a viral mechanic, before you invest further. That audit deserves its own full pass rather than a guess.
For your first no-cost validation test, see how to validate a business idea with no money (7 free tests).Once you’ve reframed or confirmed your idea, the next step is running it through the full 7-day validation sprint.
Related: 9 signs your business idea won’t work (check them before you build).
Frequently Asked Questions
What’s the difference between a painkiller and a vitamin startup idea?
A painkiller solves an urgent, costly problem people are already spending money or time trying to fix. A vitamin makes life slightly better but is easy to postpone. Because 43% of failed startups cited poor product-market fit (CB Insights, 2025), that distinction is usually the first thing worth testing.
Can a vitamin business idea still succeed?
Yes, but it usually needs a real distribution edge, like an existing audience, a viral loop, or a habit mechanic, to compensate for the lack of built-in urgency. Early Instagram and early Slack are classic examples. Without that edge, Startup Genome found roughly 70% of startups scale prematurely and struggle (Startup Genome).
What is a “candy” product?
Candy is fun, social, or aesthetically pleasing, but neither urgent nor deeply needed, think novelty apps, meme generators, or quiz sites. People enjoy candy while it’s around but wouldn’t miss it much if it disappeared. It grows on virality and habit loops rather than urgent demand, which most painkiller/vitamin frameworks overlook entirely.
How many pain markers does my idea need to pass?
Two or more out of three: urgent, costly, and already being worked around. That’s the exact threshold taught in the Ideas Into Income Academy’s validation curriculum, Lesson 1.1.2. Scoring zero or one means it’s worth revisiting your idea before spending another hour building it.
What’s the fastest way to test if my idea is a painkiller?
Run the 5-minute scorecard: score your idea yes or no on urgency, cost, and existing workarounds. Two or more yeses means keep going. Among a 2022 cohort of SaaS unicorns, roughly 80% were classified as painkillers versus under 20% vitamins (SaaS Club / Knight Capital, 2022), which is why this quick filter matters before you build.
The bottom line
The 3-marker test is the fastest filter you can run on a new idea: is it urgent, is it costly, and are people already working around it? Score two or more yeses, and you’re likely holding a painkiller worth pursuing. Score zero or one, and you’ve just saved yourself months by finding out now instead of after you’ve built something.
Remember the third category too. Candy ideas aren’t painkillers or vitamins, they grow through virality and habit loops instead of urgent demand, and mistaking one for the other leads to the wrong growth strategy.
Run the test on your idea today, then bring your score to people who’ve run it before.
Ready to score your idea? Join the free Ideas Into Income community, post your painkiller/vitamin/candy score, and get honest feedback before you build anything. → Join free on Skool →
Next in the VALIDATE series: how to validate a business idea with no money (7 free tests).
Results disclaimer: Ideas Into Income Academy teaches a validation process. We make no guarantee of income, revenue, or business results. Outcomes depend on your effort, market, and execution. The niche examples in this post (meal-planning, fitness, freelancing) are illustrative only and do not represent real client results or case studies. Nothing here is financial or legal advice.
Sources
- CB Insights, “Why Startups Fail: Top Reasons” — retrieved 2026-07-05
- LendingTree, “Small Business Failure Rate” (analysis of U.S. Bureau of Labor Statistics Business Employment Dynamics data) — retrieved 2026-07-05
- Startup Genome, “A Deep Dive Into the Anatomy of Premature Scaling” — retrieved 2026-07-05
- SaaS Club, “Painkiller vs. Vitamin” framework analysis citing Knight Capital, Q1 2022 SaaS unicorn cohort — retrieved 2026-07-05 (directional industry analysis, not peer-reviewed)